Kininogen inhibitors

Details Kininogen inhibitors Kininogen inhibitors

1996-05-16

2000-08-01

Celsa, Bennett

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 18, 530331, 562 56, C07K 506

Patent

active

060967129

ABSTRACT:
Kininogenase inhibiting peptides or peptide analogues with C-terminal related to agmatine or noragmatine.

REFERENCES:
patent: 4568636 (1986-02-01), Svendsen
patent: 4713369 (1987-12-01), Stuber
patent: 4927809 (1990-05-01), Stuber
patent: 5519005 (1996-05-01), Lider et al.
"Inhibition of Thrombin with H-and Boc-D-Phe-Pro-Agm", Peptides, 1983, Walter de Gruyter & Co., Berlin .cndot. New York.
Experientia, 25/6, pp. 573-574.
Chemical Abstracts vol. 108, p. 1563139 (Braz. J. Med. Biol. Res. 1987, 20(5), 511-520.
J. Biochem 1988, 104, 200-206.
Life Sciences 1985, 37, 1015-1022.

Affiliated with

Also associated with

Rating

Kininogen inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kininogen inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kininogen inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-663921